Northwest & Ethical Investments’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-600
Closed -$53.7K 422
2018
Q3
$53.7K Sell
600
-500
-45% -$44.2K ﹤0.01% 350
2018
Q2
$87.4K Buy
1,100
+200
+22% +$16.6K 0.01% 351
2018
Q1
$80.3K Sell
900
-11,255
-93% -$1.08M 0.01% 347
2017
Q4
$1.24M Sell
12,155
-19,787
-62% -$2.23M 0.08% 262
2017
Q3
$4.67M Buy
31,942
+3,765
+13% +$513K 0.29% 86
2017
Q2
$3.66M Sell
28,177
-6,500
-19% -$796K 0.25% 114
2017
Q1
$4.31M Buy
34,677
+20,093
+138% +$2.4M 0.29% 92
2016
Q4
$1.69M Buy
+14,584
New +$1.62M 0.12% 209

Other funds holding CELG

Northwest & Ethical Investments's CELG Position: Q4 2018 in Review

Northwest & Ethical Investments sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 600 shares — an estimated $53.7K sold.

Northwest & Ethical Investments first reported a position in CELG in Q4 2016 and held it in 8 quarters. The position peaked at $4.67M in Q3 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Northwest & Ethical Investments reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Northwest & Ethical Investments sold 600 Celgene Corp shares in Q4 2018, an estimated $53.7K.
  • Northwest & Ethical Investments first reported a position in Celgene Corp in Q4 2016 and held it in 8 quarters.
  • Northwest & Ethical Investments's Celgene Corp position peaked at $4.67M in Q3 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Northwest & Ethical Investments's 13F filing for Q4 2018, filed 8 Jul 2025.